Allspring Global Investments’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$255K	Buy	19,240 +1,990	+12%	+$25.3K	﹤0.01%	1559
2025 Q4	$159K	Buy	17,250 +1,333	+8%	+$18.4K	﹤0.01%	1596
2025 Q3	$299K	Sell	15,917 -21	-0.1%	-$259	﹤0.01%	1485
2025 Q2	$157K	Sell	15,938 -860	-5%	-$7.06K	﹤0.01%	1564
2025 Q1	$112K	Buy	16,798 +3,935	+31%	+$39.7K	﹤0.01%	1690
2024 Q4	$157K	Buy	12,863 +1,582	+14%	+$24.7K	﹤0.01%	1692
2024 Q3	$232K	Buy	11,281 +394	+4%	+$9.08K	﹤0.01%	1650
2024 Q2	$244K	Buy	10,887 +1,993	+22%	+$47.5K	﹤0.01%	1670
2024 Q1	$245K	Buy	8,894 +750	+9%	+$20.8K	﹤0.01%	1663
2023 Q4	$248K	Buy	8,144 +582	+8%	+$16.7K	﹤0.01%	1651
2023 Q3	$239K	Sell	7,562 -107	-1%	-$4.15K	﹤0.01%	1716
2023 Q2	$313K	Buy	7,669 +3,393	+79%	+$138K	﹤0.01%	1678
2023 Q1	$159K	Sell	4,276 -816	-16%	-$32K	﹤0.01%	1885
2022 Q4	$178K	Sell	5,092 -65	-1%	-$3.09K	﹤0.01%	1865
2022 Q3	$288K	Sell	5,157 -293	-5%	-$18.2K	﹤0.01%	1710
2022 Q2	$282K	Sell	5,450 -25,046	-82%	-$1.27M	﹤0.01%	1723
2022 Q1	$2.22M	Sell	30,496 -1,520	-5%	-$129K	﹤0.01%	1452
2021 Q4	$3.79M	Buy	+32,016	New	+$4.01M	﹤0.01%	1275